Source comparison
BPC-157 for Plantar Fasciitis: Treatment Comparison
Conservative Care Load modification, fascia stretching, eccentric strengthening Daily stretching + orthotics for 6–12 months High (Level 1 RCTs) $50–$300 First-line treatment. Resolves 70% of cases without invasive intervention PRP Injections Autologous growth
This comparison does not assign a generated winner or score.
- Conservative Care
- Load modification, fascia stretching, eccentric strengthening
- Daily stretching + orthotics for 6–12 months
- High (Level 1 RCTs)
- $50–$300
- First-line treatment. Resolves 70% of cases without invasive intervention
- PRP Injections
- Autologous growth factors trigger collagen remodeling and reduce inflammation
- 1–3 injections spaced 4–6 weeks apart
- Moderate (Level 2 studies)
- $500–$1,500/injection
- Evidence-based option when conservative care fails. FDA-cleared for soft tissue injuries
- Corticosteroid Injection
- Reduces acute inflammation but does not promote tissue regeneration
- Single injection
- Moderate (short-term relief)
- $100–$300
- Temporary symptom relief. Increases fascia rupture risk with repeated use
- BPC-157 Peptide
- Promotes angiogenesis and Type I collagen synthesis at injury site
- 250–300 mcg subcutaneous daily for 4–8 weeks
- Low (animal models, case reports)
- $150–$400/course
- Research peptide with regenerative potential. Not FDA-approved, lacks Phase 3 human trials
- Extracorporeal Shockwave
- Mechanical stress induces microtrauma that stimulates healing response
- 3–5 sessions over 3–6 weeks
- $1,500–$3,000 total
- Non-invasive option with 60–70% success rate in refractory cases
- Surgical Release
- Partial fasciotomy to reduce tension and remove degenerative tissue
- Single procedure
- High (for refractory cases)
- $5,000–$10,000
- Reserved for cases unresponsive to 12+ months of conservative and minimally invasive care